| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 73, 503-510, Copyright © 1986 by American Heart Association
K Chadda, S Goldstein, R Byington and JD Curb
The incidence of congestive heart failure was studied in the Beta Blocker
Heart Attack Trial in which postmyocardial infarction patients between the
ages of 30 and 69 years, with no contraindication to propranolol, were
randomly assigned to receive placebo (n = 1921) or propranolol 180 or 240
mg daily (n = 1916) 5 to 21 days after admission to the hospital for the
event. Survivors of acute myocardial infarction with compensated or mild
congestive heart failure, including those on digitalis and diuretics, were
included in the study. A history of congestive heart failure before
randomization characterized 710 (18.5%) patients: 345 (18.0%) in the
propranolol group and 365 (19.0%) in the placebo group. The incidence of
definite congestive heart failure after randomization and during the study
was 6.7% in both groups. In patients with a history of congestive heart
failure before randomization, 51 of 345 (14.8%) in the propranolol group
and 46 of 365 (12.6%) in the placebo group developed congestive heart
failure during an average 25 month follow-up. In the patients with no
history of congestive heart failure, 5% in the propranolol group developed
congestive heart failure and 5.3% in the placebo group developed congestive
heart failure. Baseline characteristics predictive of the occurrence of
congestive heart failure by multivariate analyses included an increased
cardiothoracic ratio, diabetes, increased heart rate, low baseline weight,
prior myocardial infarction, age, and more than 10 ventricular premature
beats per hour.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
This article has been cited by other articles:
 |
|
 |
|
  S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]
|
|
|
|
 |
|
 2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Filippatos and D. T. Kremastinos Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block? Eur. Heart J., May 1, 2007; 28(9): 1170 - 1171. [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Howard, J. W. Cheng, M. A Crouch, V. J Colucci, J. S Kalus, S. A Spinler, and M. Munger Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure Ann. Pharmacother., September 1, 2006; 40(9): 1607 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the American Colle, Endorsed by the Heart Rhythm Society, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1116 - 1143. [Full Text] [PDF]
|
|
|
|
|
|
M. Josephson and H. J.J. Wellens Implantable Defibrillators and Sudden Cardiac Death Circulation, June 8, 2004; 109(22): 2685 - 2691. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Kernis, K. J. Harjai, G. W. Stone, L. L. Grines, J. A. Boura, W. W. O'Neill, and C. L. Grines Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1773 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tavazzi Heart rate as a therapeutic target in heart failure? Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G15 - G18. [Abstract] [PDF]
|
|
|
|
|
|
M.A. Pfeffer The intersection between acute coronary syndrome and heart failure Eur. Heart J. Suppl., April 1, 2003; 5(suppl_C): C19 - C23. [Abstract] [PDF]
|
|
|
|
|
|
A. H. Wu, L. Parsons, N. R. Every, and E. R. Bates Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2) J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1389 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade and S. Goldstein {beta}-Blockers in the Post-Myocardial Infarction Patient Circulation, July 23, 2002; 106(4): 394 - 398. [Full Text] [PDF]
|
|
|
|
|
|
F. A. Spencer, T. E. Meyer, J. M. Gore, and R. J. Goldberg Heterogeneity in the Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Heart Failure: The National Registry of Myocardial Infarction Circulation, June 4, 2002; 105(22): 2605 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goldstein Benefits of {beta}-Blocker Therapy for Heart Failure: Weighing the Evidence Arch Intern Med, March 25, 2002; 162(6): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Farrell, J. M. Foody, and H. M. Krumholz {beta}-Blockers in Heart Failure: Clinical Applications JAMA, February 20, 2002; 287(7): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H Jagasia and K. Shivkumar Carvedilol reduced mortality and morbidity caused by myocardial infarction in patients with left ventricular dysfunction Evid. Based Med., January 1, 2002; 7(1): 15 - 15. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Persson, K. Andreasson, T. Kahan, S. V. Eriksson, B. Tidgren, P. Hjemdahl, C. Hall, and L. Erhardt Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists Eur J Heart Fail, January 1, 2002; 4(1): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Brophy, L. Joseph, and J. L. Rouleau {beta}-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis Ann Intern Med, April 3, 2001; 134(7): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Galcera-Tomas, F. J. Castillo-Soria, M. Villegas-Garcia, R. Florenciano-Sanchez, J. G. Sanchez-Villanueva, J. A. N. de la Rosa, A. Martinez-Caballero, J. A. Valenti-Aldeguer, P. Jara-Perez, M. Parraga-Ramirez, et al. Effects of Early Use of Atenolol or Captopril on Infarct Size and Ventricular Volume : A Double-Blind Comparison in Patients With Anterior Acute Myocardial Infarction Circulation, February 13, 2001; 103(6): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Houghton, N. Freemantle, and J. G.F. Cleland Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials Eur J Heart Fail, September 1, 2000; 2(3): 333 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nademanee, R. Taylor, W. E. Bailey, D. E. Rieders, and E. M. Kosar Treating Electrical Storm : Sympathetic Blockade Versus Advanced Cardiac Life Support-Guided Therapy Circulation, August 15, 2000; 102(7): 742 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rifkin, S. Walerstein, D. H. Wiener, and B. Fagerberg {beta}-Blockade for Patients With Heart Failure JAMA, July 26, 2000; 284(4): 436 - 437. [Full Text] [PDF]
|
|
|
|
|
|
W. T. Abraham {beta}-Blockers: The New Standard of Therapy for Mild Heart Failure Arch Intern Med, May 8, 2000; 160(9): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bonet, A. Agusti, J. M. Arnau, X. Vidal, E. Diogene, E. Galve, and J.-R. Laporte {beta}-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials Arch Intern Med, March 13, 2000; 160(5): 621 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Sharma, J. S.M. Sarma, and B. N. Singh Effects of Sotalol on the Circadian Rhythmicity of Heart Rate and QT Intervals With a Noninvasive Index of Reverse-Use Dependency Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(1): 15 - 21. [Abstract] [PDF]
|
|
|
|
 |
|
 K S Spargias, A S Hall, D C Greenwood, and S G Ball beta Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study Heart, January 1, 1999; 81(1): 25 - 32. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Torp-Pedersen, L. Kober, S. S. Gottlieb, R. J. McCarter, and R. A. Vogel Beta-Blockers after Myocardial Infarction N. Engl. J. Med., December 31, 1998; 339(27): 2022 - 2023. [Full Text]
|
|
|
|
|
|
S. S. Gottlieb, R. J. McCarter, and R. A. Vogel Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction N. Engl. J. Med., August 20, 1998; 339(8): 489 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Domanski, D. P. Zipes, and E. Schron Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions Circulation, June 17, 1997; 95(12): 2694 - 2699. [Full Text]
|
|
|
|
|
|
K. Ogunyankin and B. N. Singh Reflections on Recent Clinical Trials in Patients With Heart Failure and Those With Reduced Ventricular Function Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 147 - 152. [PDF]
|
|
|
|
|
|
P. C. Deedwania Sotalol Is More Powerful Than Propranolol in Suppressing Complex Ventricular Arrhythmias Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 259 - 272. [Abstract] [PDF]
|
|
|
|
|
|
S. Goldstein {beta}-Blockers in Hypertensive and Coronary Heart Disease Arch Intern Med, June 24, 1996; 156(12): 1267 - 1276. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation, December 15, 1995; 92(12): 3593 - 3612. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Sackner-Bernstein and D. M. Mancini Rationale for Treatment of Patients With Chronic Heart Failure With Adrenergic Blockade JAMA, November 8, 1995; 274(18): 1462 - 1467. [Abstract] [PDF]
|
|
|
|
|
|
K. B. James, P. M. McCarthy, J. D. Thomas, R. Vargo, R. E. Hobbs, S. Sapp, and E. Bravo Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure Circulation, November 1, 1995; 92(9): 191 - 195. [Abstract] [Full Text]
|
|
|
|
|
|
COMMITTEE MEMBERS, J. F. WILLIAMS Jr, M. R. BRISTOW, M. B. FOWLER, G. S. FRANCIS, A. GARSON Jr, B. J. GERSH, D. F. HAMMER, M. A. HLATKY, C. V. LEIER, et al. Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) Circulation, November 1, 1995; 92(9): 2764 - 2784. [Full Text]
|
|
|
|
|
|
H. Krum, J. D. Sackner-Bernstein, R. L. Goldsmith, M. L. Kukin, B. Schwartz, J. Penn, N. Medina, M. Yushak, E. Horn, S. D. Katz, et al. Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure Circulation, September 15, 1995; 92(6): 1499 - 1506. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Eaton, R. J. Cody, E. Nunziata, and P. F. Binkley Early Left Ventricular Dysfunction Elicits Activation of Sympathetic Drive and Attenuation of Parasympathetic Tone in the Paced Canine Model of Congestive Heart Failure Circulation, August 1, 1995; 92(3): 555 - 561. [Abstract] [Full Text]
|
|
|
|
|
|
Effects of Carvedilol, a Vasodilator–ß-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease Circulation, July 15, 1995; 92(2): 212 - 218. [Abstract] [Full Text]
|
|
|
|
|
|
E. F. Ellerbeck, S. F. Jencks, M. J. Radford, Timothy F., A. S. Craig, J. A. Gold, H. M. Krumholz, and R. A. Vogel Quality of Care for Medicare Patients With Acute Myocardial Infarction: A Four-State Pilot Study From the Cooperative Cardiovascular Project JAMA, May 17, 1995; 273(19): 1509 - 1514. [Abstract] [PDF]
|
|
|
|
 |
|
 A D Flapan Fortnightly Review: Management of patients after their first myocardial infarction BMJ, October 29, 1994; 309(6962): 1129 - 1134. [Full Text]
|
|
|
|
|
|
H J Dargie and J J V McMurray Fortnightly Review: Diagnosis and management of heart failure BMJ, January 29, 1994; 308(6924): 321 - 328. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Rouleau, L. A. Moye, M. A. Pfeffer, J. M. O. Arnold, V. Bernstein, T. E. Cuddy, G. R. Dagenais, E. M. Geltman, S. Goldman, D. Gordon, et al. A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United States N. Engl. J. Med., March 18, 1993; 328(11): 779 - 784. [Abstract] [Full Text]
|
|
|
|
|
|
Adult Advanced Cardiac Life Support JAMA, October 28, 1992; 268(16): 2199 - 2241. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Feldman Can We Alter Survival in Patients With Congestive Heart Failure? JAMA, April 8, 1992; 267(14): 1956 - 1961. [Abstract] [PDF]
|
|
|
|
|
|
D. E. Forman and J. Y. Wei {beta}-Blockade in Older Patients With Myocardial Infarction JAMA, October 23, 1991; 266(16): 2222 - 2222. [Abstract] [PDF]
|
|
|
|
|
|
S. O, Gottlieb, S. H. Gottlieb, S. C. Achuff, R. Baumgardner, E. D. Mellits, M. L. Weisfeldt, and G. Gerstenblith Silent Ischemia on Holter Monitoring Predicts Mortality in High-Risk Postinfarction Patients JAMA, February 19, 1988; 259(7): 1030 - 1035. [Abstract] [PDF]
|
|
|
|
|
|
K. P. ANDERSON, R. A. FREEDMAN, and J. W. MASON Sudden Death in Idiopathic Dilated Cardiomyopathy Ann Intern Med, July 1, 1987; 107(1): 104 - 106. [Abstract] [PDF]
|
|